Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected (125)I-GLP-2
Research output: Contribution to journal › Journal article › peer-review
Glucagon-like peptide 2 (GLP-2) is a 33-amino acid (1-33) intestinotrophic peptide. In this study, the distribution and binding of i.v. injected radiolabeled GLP-2 (1-33) were investigated in rats using autoradiography in order to target possible binding sites. The major part of (125)I-GLP-2 (1-33) was distributed to kidneys, liver, and the gastrointestinal tract. In the small intestine, a high density of grains was localized in the epithelium with a predominance in the luminal part of the villus. The saturability of (125)I-GLP-2 (1-33) was investigated by administration of excess amounts of non-radioactive GLP-2 (1-33) or the primary metabolite of GLP-2 degradation, GLP-2 (3-33). In the small intestine, (125)I-GLP-2 was displaced both by non-radioactive GLP-2 (1-33) and (3-33), suggesting that the uptake of GLP-2 (1-33) in the small intestine is receptor-specific and that the metabolite GLP-2 (3-33) may interact with the GLP-2 receptor.
|Number of pages||7|
|Publication status||Published - Oct 2000|
- Animals, Autoradiography, Binding, Competitive, Epithelium, Female, Glucagon-Like Peptide 2, Glucagon-Like Peptides, Injections, Intravenous, Intestine, Small, Iodine Radioisotopes, Kidney, Liver, Peptides, Protein Binding, Radioimmunoassay, Rats, Rats, Wistar, Receptors, Glucagon, Substrate Specificity